Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse.
Hogan LE, Brown PA, Ji L, Xu X, Devidas M, Bhatla T, Borowitz MJ, Raetz EA, Carroll A, Heerema NA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Hunger SP, Loh ML. Hogan LE, et al. Among authors: terezakis sa. J Clin Oncol. 2023 Sep 1;41(25):4118-4129. doi: 10.1200/JCO.22.02200. Epub 2023 May 31. J Clin Oncol. 2023. PMID: 37257143 Free PMC article. Clinical Trial.
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
DuBois SG, Krailo MD, Glade-Bender J, Buxton A, Laack N, Randall RL, Chen HX, Seibel NL, Boron M, Terezakis S, Hill-Kayser C, Hayes A, Reid JM, Teot L, Rakheja D, Womer R, Arndt C, Lessnick SL, Crompton BD, Kolb EA, Daldrup-Link H, Eutsler E, Reed DR, Janeway KA, Gorlick RG. DuBois SG, et al. J Clin Oncol. 2023 Apr 10;41(11):2098-2107. doi: 10.1200/JCO.22.01815. Epub 2023 Jan 20. J Clin Oncol. 2023. PMID: 36669140 Free PMC article. Clinical Trial.
Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy.
Song CW, Terezakis S, Park WY, Paek SH, Kim MS, Cho LC, Griffin RJ. Song CW, et al. Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):701-704. doi: 10.1016/j.ijrobp.2023.05.015. Epub 2023 May 16. Int J Radiat Oncol Biol Phys. 2023. PMID: 37196835 Free article. No abstract available.
Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
Shen CJ, Kry SF, Buchsbaum JC, Milano MT, Inskip PD, Ulin K, Francis JH, Wilson MW, Whelan KF, Mayo CS, Olch AJ, Constine LS, Terezakis SA, Vogelius IR. Shen CJ, et al. Among authors: terezakis sa. Int J Radiat Oncol Biol Phys. 2024 Jun 1;119(2):431-445. doi: 10.1016/j.ijrobp.2023.06.007. Epub 2023 Aug 11. Int J Radiat Oncol Biol Phys. 2024. PMID: 37565958
How safe is safe? Risk in radiotherapy.
Ford EC, Terezakis S. Ford EC, et al. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):321-2. doi: 10.1016/j.ijrobp.2010.04.047. Int J Radiat Oncol Biol Phys. 2010. PMID: 20832662 No abstract available.
146 results